Celladon Hopes To Bring Gene-Therapy Solution To Heart Failure Patients

Improving heart contractility by increasing levels of the SERCA2a gene is a new approach to a familiar problem in treating heart failure.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet